Modern mental health company Clerkenwell Health announced today that it is working with clinical-stage biotechnology company Beckley Psytech on a Phase IIa study investigating whether a novel psychedelic compound, combined with psychological support, could be an effective treatment for alcohol use disorder (AUD).
New study to test novel psychedelic compound as potential treatment for alcohol use disorder
- Thread starter Educator
- Start date